Form 4: Nuvalent CEO James Richard Porter Executes Stock Option and Sells Shares Under 10b5-1 Plan
SEC Form 4
James Richard Porter, President and CEO of Nuvalent, Inc., exercised stock options and sold shares of Class A Common Stock under a pre-arranged 10b5-1 trading plan.
Summary
- On May 15, 2025, James Richard Porter, the President and CEO of Nuvalent, Inc., executed a stock option to acquire 27,000 shares of Class A Common Stock at a price of $27.85 per share.
- Concurrently, Porter sold a total of 27,000 shares of Class A Common Stock in multiple transactions at weighted average prices of $69.28, $69.99 and $70.77.
- These transactions were executed under a Rule 10b5-1 trading plan adopted on April 2, 2024.
- Following these transactions, Porter directly owns 249,062 shares of Class A Common Stock and holds options for 204,780 shares.
Sentiment
Score: 7
Explanation: The sentiment is neutral to slightly positive. The transactions are part of a pre-planned strategy, and the CEO maintains a significant stake in the company.
Positives
- The use of a 10b5-1 trading plan suggests that the sales were pre-planned and not based on insider information.
Risks
- Executive stock sales can sometimes be perceived negatively by investors, although the use of a 10b5-1 plan mitigates this concern.
Future Outlook
The document does not contain specific forward-looking statements, but the CEO's continued stock ownership and option holdings suggest a continued alignment with the company's success.
Industry Context
Executive stock transactions are common and closely monitored, especially in publicly traded companies. The use of a 10b5-1 plan is a standard practice to avoid accusations of insider trading.
Comparison to Industry Standards
- Executive compensation packages often include stock options and restricted stock units to align management's interests with those of shareholders.
- The vesting schedule of the options (four years with monthly installments) is a typical arrangement.
- The use of 10b5-1 trading plans is a common practice among executives to manage their stock sales in a transparent and compliant manner.
Stakeholder Impact
- The transactions could have a minor impact on shareholders, depending on their interpretation of executive stock sales.
- The use of a 10b5-1 plan should reassure stakeholders that the sales were not based on inside information.
Key Dates
| Date | Description |
|---|---|
| 01/06/2023 | Start date for vesting of shares underlying the option. |
| April 2, 2024 | Date the 10b5-1 trading plan was adopted. |
| 05/15/2025 | Date of the stock option exercise and stock sales. |
| 01/06/2033 | Expiration date of the stock option. |
Keywords
Nuvalent, James Richard Porter, stock options, Form 4, 10b5-1 trading plan, executive compensation, insider trading, NUVL, stock sale
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.